BioNTech, Ryvu Therapeutics ink pact for Immuno-Modulatory Small Molecule Candidates Ruchika Sharma4 Dec 2022 7:00 AMUnder the terms of the agreement, BioNTech will pay Ryvu an upfront fee of €20 million in exchange for certain rights to Ryvu’s STING agonist...
BioNTech affiliate to acquire Novartis GMP-certified manufacturing facility in Singapore Ruchika Sharma15 Nov 2022 11:02 AMSingapore: BioNTech SE has announced its Singapore affiliate BioNTech Pharmaceuticals Asia Pacific Pte. Ltd. had entered into an agreement...
Pfizer, BioNTech get positive CHMP opinion for Omicron BA.4/BA.5-Adapted Bivalent COVID vaccine booster for children 5 through 11 years of age in EU Ruchika Sharma13 Nov 2022 8:30 AM-New York: Pfizer Inc. and BioNTech SE have announced a booster dose of their Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine (COMIRNATY...
Pfizer-BioNTech to test combined COVID, influenza vaccine Ruchika Sharma4 Nov 2022 10:10 AMFrankfurt: Pfizer-BioNTech said they will test a combined coronavirus and influenza vaccine, which could potentially pave the way for better...
Pfizer gets USFDA Emergency Use Authorization for bivalent omicron booster in children aged 5 through 11 years Ruchika Sharma13 Oct 2022 10:30 AMNew York: Pfizer Inc. and BioNTech SE have announced that the U.S. Food and Drug Administration (USFDA) has granted Emergency Use Authorization...
BioNTech, Australia collaborate to establish mRNA Research Center Ruchika Sharma9 Oct 2022 4:30 AMAustralia: BioNTech SE has announced that the company has agreed a Letter of Intent with the State of Victoria in Australia on a strategic...
Pfizer-BioNTech Omicron retooled booster authorised in Canada Ruchika Sharma8 Oct 2022 7:47 AMRegulators in the European Union and Japan have also cleared Pfizer's updated booster shot.
Pfizer, BioNTech complete submission to EMA for Omicron BA.4/BA.5-Adapted Bivalent vaccine booster in children aged 5 Through 11 years Ruchika Sharma2 Oct 2022 10:15 AMCOMIRNATY, which is based on BioNTech's proprietary mRNA technology, was developed by both BioNTech and Pfizer.
Pfizer, BioNTech seek USFDA emergency use nod for Omicron BA.4/BA.5-Adapted Bivalent Vaccine Booster for Children aged 5 through 11 years Ruchika Sharma27 Sept 2022 5:45 AMCOMIRNATY (COVID-19 Vaccine, mRNA) is a vaccine approved for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute...
CEO of Pfizer tests COVID positive again Ruchika Sharma26 Sept 2022 8:15 AMThe chief executive said he has not yet taken the new bivalent booster.
Pfizer COVID vaccine approved for children as young as six months in Brazil Ruchika Sharma19 Sept 2022 8:00 AMRio De Janeiro: Brazilian national health regulator Anvisa has approved the COVID-19 vaccine produced by Pfizer and BioNTech for children aged between...
Pfizer- BioNTech get positive CHMP opinion for conversion of COMIRNATY conditional marketing nod to full marketing nod in EU Ruchika Sharma18 Sept 2022 3:30 AMNew Delhi: Pfizer and BioNTech have announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA)...
